News
Vetter wins Axia Best Managed Company Award
A look at vital figures makes it clear that Vetter is a very successful, globally active Contract Development and Manufacturing Organization (CDMO). Over the last...
News
GSK partners with Samsung Biologics to secure additional manufacturing...
GlaxoSmithKline and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s innovative biopharmaceutical therapies.
Under the terms...
Clinical Trials
Roche’s Port Delivery System with ranibizumab shows positive phase...
Roche announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or “wet”...
Clinical Trials
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical...
News
Thermo Fisher Scientific Extends Collaboration with Biognosys to Enhance...
Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation proteomics solutions, announce they are continuing their collaboration to...
News
Merck to acquire Themis for SARS-CoV-2 vaccine
Merck announced on May 26 that it has entered an agreement to acquire privately held Themis, a company that is developing a vaccine candidate for...
Drug Research
Merck and Ridgeback Bio Collaborate to Advance Development of...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.